Cargando…

A toxicity-dependent feasibility bound for the escalation with overdose control approach in phase I cancer trials

Detalles Bibliográficos
Autores principales: Wheeler, Graham, Sweeting, Michael, Mander, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660097/
http://dx.doi.org/10.1186/1745-6215-16-S2-P233
_version_ 1782402731301928960
author Wheeler, Graham
Sweeting, Michael
Mander, Adrian
author_facet Wheeler, Graham
Sweeting, Michael
Mander, Adrian
author_sort Wheeler, Graham
collection PubMed
description
format Online
Article
Text
id pubmed-4660097
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46600972015-12-02 A toxicity-dependent feasibility bound for the escalation with overdose control approach in phase I cancer trials Wheeler, Graham Sweeting, Michael Mander, Adrian Trials Poster Presentation BioMed Central 2015-11-16 /pmc/articles/PMC4660097/ http://dx.doi.org/10.1186/1745-6215-16-S2-P233 Text en Copyright © 2015 Wheeler et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Wheeler, Graham
Sweeting, Michael
Mander, Adrian
A toxicity-dependent feasibility bound for the escalation with overdose control approach in phase I cancer trials
title A toxicity-dependent feasibility bound for the escalation with overdose control approach in phase I cancer trials
title_full A toxicity-dependent feasibility bound for the escalation with overdose control approach in phase I cancer trials
title_fullStr A toxicity-dependent feasibility bound for the escalation with overdose control approach in phase I cancer trials
title_full_unstemmed A toxicity-dependent feasibility bound for the escalation with overdose control approach in phase I cancer trials
title_short A toxicity-dependent feasibility bound for the escalation with overdose control approach in phase I cancer trials
title_sort toxicity-dependent feasibility bound for the escalation with overdose control approach in phase i cancer trials
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660097/
http://dx.doi.org/10.1186/1745-6215-16-S2-P233
work_keys_str_mv AT wheelergraham atoxicitydependentfeasibilityboundfortheescalationwithoverdosecontrolapproachinphaseicancertrials
AT sweetingmichael atoxicitydependentfeasibilityboundfortheescalationwithoverdosecontrolapproachinphaseicancertrials
AT manderadrian atoxicitydependentfeasibilityboundfortheescalationwithoverdosecontrolapproachinphaseicancertrials
AT wheelergraham toxicitydependentfeasibilityboundfortheescalationwithoverdosecontrolapproachinphaseicancertrials
AT sweetingmichael toxicitydependentfeasibilityboundfortheescalationwithoverdosecontrolapproachinphaseicancertrials
AT manderadrian toxicitydependentfeasibilityboundfortheescalationwithoverdosecontrolapproachinphaseicancertrials